TP53 and diffuse large B-cell lymphoma: Regarding the tumor suppressor TP53 co-overexpressing with COPS5 in the DLBCL-related CPM, since the CPM contained MYC and TP53 mutations also, our results suggest the importance of understanding the orchestration of multimodal features.